Morning Overview on MSN

LLMs have tons of parameters, but what is a parameter?

Large language models are routinely described in terms of their size, with figures like 7 billion or 70 billion parameters ...

Why AI Threat Models In Finance Must Follow The Data, Not The Code

For financial institutions, threat modeling must shift away from diagrams focused purely on code to a life cycle view ...
TMCnet

Variant Bio Announces Strategic Target Discovery Collaboration with Boehringer Ingelheim for Kidney Disease

Variant Bio's Inference platform uses LLM technology, machine learning, and advanced statistical genetics to analyze hundreds of billions of data points, moving from genetic association to validated ...

Variant Bio Launches Inference, the World's First Agentic AI Genomic Drug Discovery Platform

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

Semiconductor Spending Is Set to Hit $1 Trillion in 2026: 2 Top Stocks to Buy Before That Happens, According to a Wall Street Analyst

Investors looking to buy top semiconductor stocks for 2026 should take a closer look at these names before they fly higher.

Simulated Truths: How Synthetic Data Is Rewriting Institutional Perception

First, institutions must ensure that synthetic datasets are continuously recalibrated against fresh, real-world evidence. The ...
BMJ

Causal inference is hard, and advanced statistical analysis is not enough

Health researchers need to fully understand the underlying assumptions to uncover cause and effect. Timothy Feeney and Paul Zivich explain Physicians ask, answer, and interpret myriad causal questions ...